| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.062 | 0.07 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.08 | 0.07 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |